We provide our colleagues in industry direct access to our faculty, proprietary technologies and specialized preclinical and clinical research capabilities, so together we can turn scientific discoveries, ours and industry’s, into life improving products.
Winston-Salem, NC (PRWEB) January 30, 2015
Jeff Brennan has been named Vice President, Industry Relations & Business Development at Wake Forest Innovations.
In this newly created position, Brennan will engage with industry to form business arrangements across a broad range of scientific and clinical research operations. Brennan’s role has national and international reach in the pharmaceutical, biotechnology, medical device and clinical diagnostics industries.
“Wake Forest Innovations has adopted an Open Innovation engagement model used today by many sectors of industry,” said Eric Tomlinson, D.Sc., Ph.D., Wake Forest Baptist Medical Center’s chief innovation officer. “We provide our colleagues in industry direct access to our faculty, proprietary technologies and specialized preclinical and clinical research capabilities, so together we can turn scientific discoveries, ours and industry’s, into life improving products.”
Brennan will lead the newly formed Industry Relations & Business Development Department of Wake Forest Innovations with direct responsibility for several core services including: Business Development, Market Analytics, Intellectual Property Management, Technology Licensing, New Company Formation and Incubation, and Contract R&D Services Sales.
As a member of Wake Forest Innovations executive leadership team, Brennan and his colleagues will work with the product accelerators of Wake Forest Innovations (therapeutics/vaccines, medical devices and diagnostics) to support the development of proprietary technologies for commercialization through licensing to industry.
To promote and contract specialized preclinical and clinical research & development capabilities to industry, government and other institutions, Brennan will work with both Contract Research & Development Services at Wake Forest Innovations and the Office of Sponsored Research at Wake Forest School of Medicine.
In addition, Brennan will work with the Dean of the School of Medicine, the Senior Associate Dean for Clinical and Translational Research and faculty to engage industry to secure funding for basic science programs.
Brennan comes to Wake Forest after a career in industry with senior business development responsibility at several organizations including Sanofi, Inc., and most recently at Targacept, Inc.
“Jeff has successfully developed and negotiated major product licensing and commercialization agreements with industry, established start-ups, and executed major research agreements between academia and industry, which made him the ideal candidate to lead the Industry Relations & Business Development Department that supports our open innovation engagement model with industry,” Tomlinson added.
About Wake Forest Innovations
Wake Forest Innovations is responsible for accelerating the commercialization of the ideas, discoveries and specialized research capabilities of Wake Forest Baptist Medical Center, a fully integrated, internationally recognized academic medical center. Wake Forest Innovations establishes arrangements with industry across a broad range of scientific and clinical research operations, including agreements for the development and commercialization of proprietary technologies and products, contracts to provide specialized preclinical and clinical research services, and agreements to sponsor basic scientific research. Core departments include: Product Innovation Services, responsible for investing in and developing proprietary technology ready for licensing; Contract Research & Development Services, responsible for structuring and managing the provision of specialized preclinical and clinical research capabilities to industry; and Industry Relations & Business Development, responsible for engaging industry with an open innovation model to commercialize proprietary products and specialized research capabilities through licensing, sponsored research and fee-for-service contracts.